FDA Advisory Panel Recommends Compounding for Popular Peptides Amidst Regulatory Tensions and Insulin Supply Hurdles.
In a landmark decision that signals a profound shift in the American regulatory landscape, an...
In a landmark decision that signals a profound shift in the American regulatory landscape, an...
The most immediate concern for millions of patients living with diabetes is the announcement of...
The transition of executive leadership within the biotechnology sector often serves as a bellwether for...
The landscape of American pharmaceutical regulation underwent a significant shift this week as a Food...
The fundamental principle of public health rests on a simple yet profound realization: food safety...
The rapid escalation of cases in 2026 has officially made this the nation’s most severe...
The landscape of American healthcare and federal science policy is undergoing a seismic shift, marked...
As the 2026 academic year commences, a profound shift in the landscape of American higher...
The United States is currently facing a burgeoning public health challenge as federal health officials...
The Pharmacy Compounding Advisory Committee (PCAC) held the first of two days of intensive deliberations...